Comparison of Molecular (Blueprint and Mammaprint) and Pathological Subtypes for Breast Cancer Among the First 800 Patients from the Eortc 10041/Big 3-04 (Mindact) Trial.
AuthID
P-00P-6MH
P-00P-6MH
© 2024 CRACS & Inesc TEC - All Rights Reserved Privacy Policy | Terms of Service